Skip to main content
SpringerLink
Log in

Quality of life in psoriasis

  • Chapter
  • First Online:
Handbook of Psoriasis and Psoriatic Arthritis

Abstract

Psoriasis can affect health-related quality of life (HRQoL) to an extent similar to the effects of other severe chronic diseases such as depression, myocardial infarction, cancer, or hypertension [1]. The visible nature of psoriasis can be particularly disabling [2], with evidence of stigma, lowered self-image, depression, anxiety, and suicidal ideation [3] even in mild psoriasis [1]. Psychological impairment has been observed in social settings and in the workplace [4, 5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Russo PAJ, llchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol. 2004:45:155-161.

    Google Scholar 

  2. Nelson PA, Barker Z, Griffiths CEM, Cordingley L, Chew-Graham CA. ‘On the surface’: a qualitative study of GPs’ and patients’ perspectives on psoriasis. BMC Fam Pract. 2013;14:158.

    Google Scholar 

  3. Fortune DG, Richards HL, Main C, Griffiths CEM. What patients with psoriasis believe about their condition. J Am Acad Dermatol. 1998;39:196-201.

    Google Scholar 

  4. Jong EM de, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology. 1996;193:300-303.

    Google Scholar 

  5. Zachariae R, Zachariae H, Blomqvist K, et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol. 2002;146:1006-1016.

    Google Scholar 

  6. Wahl AK, Robinson HS, Langeland E, Larsen MH, Krogstad A, Moum T. Clinical characteristics associated with illness perception in psoriasis. Acta Derm Venereol. 2014;94:271-275.

    Google Scholar 

  7. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol. 2004;51:704-708.

    Google Scholar 

  8. Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M. Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. Acta Derm Venereol. 2010;90:147-151.

    Google Scholar 

  9. Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol. 2012;26:3-11.

    Google Scholar 

  10. Montaudié H, Albert-Sabonnadiere C, Acquacalda E, et al. Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study. J Eur Acad Dermatol Venereol. 2014;28:1186-1191.

    Google Scholar 

  11. Kimball AB, Gieler U, Linder D, Sampogna F, Warren RB, Augustin M. Psoriasis: is the impairment to a patient’s life cumulative? J Eur Acad Dermatol Venereol. 2010;24:989-1004.

    Google Scholar 

  12. Reich K, Mrowietz U. Treatment goals in psoriasis. J Dtsch Dermatol Ges. 2007;5:566-574.

    Google Scholar 

  13. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137:280-284.

    Google Scholar 

  14. Dubertret L, Mrowietz U, Ranki A, et al. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol. 2006;155:729-736.

    Google Scholar 

  15. Blome C, Simianer S, Purwins S, et al. Time needed for treatment is the major predictor of quality of life in psoriasis. Dermatology. 2010;221:154-159.

    Google Scholar 

  16. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6:383-392.

    Google Scholar 

  17. Fortune DG, Richards HL, Griffiths CEM, Main CJ. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol. 2002;41:157-174.

    Google Scholar 

  18. Augustin M. Cumulative life course impairment: identifying patients at risk. Curr Probl Dermatol. 2013;44:74-81.

    Google Scholar 

  19. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin. 1996;14:485-496.

    Google Scholar 

  20. Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401-407.

    Google Scholar 

  21. Richards HL, Fortune DG, Weidmann A, Sweeney SKT, Griffiths CEM. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol. 2004;151:1227-1233.

    Google Scholar 

  22. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.

    Google Scholar 

  23. McHorney CA, Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247-263.

    Google Scholar 

  24. Rabin R, Charro F de. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337-343.

    Google Scholar 

  25. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216.

    Google Scholar 

  26. Augustin M, Zschocke I, Lange S, Seidenglanz K, Amon U. Lebensqualität bei Haut- erkrankungen: Vergleich verschiedener Lebensqualitäts-Fragebögen bei Psoriasis und atopischer Dermatitis. Hautarzt. 1999;50:715-722.

    Google Scholar 

  27. Finlay AY, Kelly SE. Psoriasis-an index of disability. Clin Exp Dermatol. 1987;12:8-11.

    Google Scholar 

  28. Lewis VJ, Finlay AY. Two decades experience of the Psoriasis Disability Index. Dermatology. 2005;210:261-268.

    Google Scholar 

  29. Augustin M, Krüger K, Radtke MA, Schwippl I, Reich K. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany. Dermatology. 2008;216:366-372.

    Google Scholar 

  30. Nast A, Boehncke WH, Mrowietz U, et al. S3-Guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges. 2012;10:1-95.

    Google Scholar 

  31. Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. 2011;303:1-10.

    Google Scholar 

  32. Radtke MA, Reich K, Blome C, Rustenbach S, Augustin M. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol. 2009;23:683-691.

    Google Scholar 

  33. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol. 2005;125:659-664.

    Google Scholar 

  34. Hariram P, Mosam A, Aboobaker J, Esterhuizen T. Quality of life in psoriasis patients in KwaZulu Natal, South Africa. Indian J Dermatol Venereol Leprol. 2011;77:333-334.

    Google Scholar 

  35. Aghaei S, Moradi A, Ardekani GS. Impact of psoriasis on quality of life in Iran. Indian J Dermatol Venereol Leprol. 2009;75:220.

    Google Scholar 

  36. Lin T, See L, Shen Y, Liang C, Chang H, Lin Y. Quality of life in patients with psoriasis in northern Taiwan. Chang Gung Med J. 2011;34:186-196.

    Google Scholar 

  37. Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol. 2004;51:704-708.

    Google Scholar 

  38. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol. 1989;20:53-63.

    Google Scholar 

  39. Richards HL, Fortune DG, Main CJ, Griffiths CEM. Stigmatization and psoriasis. Br J Dermatol. 2003;149:209-211.

    Google Scholar 

  40. Korte J de, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004;9:140-147.

    Google Scholar 

  41. Gaikwad R, Deshpande S, Raje S, Dhamdhere DV, Ghate MR. Evaluation of functional impairment in psoriasis. Indian J Dermatol Venereol Leprol. 2006;72:37-40.

    Google Scholar 

  42. Graça Pereira M, Brito L, Smith T. Dyadic adjustment, family coping, body image, quality of life and psychological morbidity in patients with psoriasis and their partners. Int J Behav Med. 2012;19:260-269.

    Google Scholar 

  43. Eghlileb AM, Davies EEG, Finlay AY. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol. 2007;156:1245-1250.

    Google Scholar 

  44. Picardi A, Abeni D, Renzi C, Braga M, Puddu P, Pasquini P. Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Derm Venereol. 2001;81:410-414.

    Google Scholar 

  45. Sojević Timotijević Z, Janković S, Trajković G, et al. Identification of psoriatic patients at risk of high quality of life impairment. J Dermatolog Treat. 2013;40:797-804.

    Google Scholar 

  46. Young M. The psychological and social burdens of psoriasis. Dermatol Nurs. 2005;17:15-19.

    Google Scholar 

  47. Varni JW, Globe DR, Gandra SR, Harrison DJ, Hooper M, Baumgartner S. Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases. Eur J Pediatr. 2012;171:485-492.

    Google Scholar 

  48. Ayala F, Sampogna F, Romano G et al. The impact of psoriasis on work-related problems: a multicenter cross-sectional survey. J Eur Acad Dermatol Venereol. 2014;28:1623-1632.

    Google Scholar 

  49. Hughes JE, Barraclough BM, Hamblin LG, White JE. Pschiatric symptoms in dermatology patients. Br J Psychol. 1983;143:51-54.

    Google Scholar 

  50. Horn EJ, Fox KM, Patel V, Chiou C, Dann F, Lebwohl M. Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol. 2007;57:963-971.

    Google Scholar 

  51. Fowler JF, Duh MS, Rovba L, et al. The impact of psoriasis on health care costs and patient work loss. J Am Acad Dermatol. 2008;59:772-780.

    Google Scholar 

  52. Kimball AB, Yu AP, Signorovitch J et al. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. J Am Acad Dermatol. 2012;66:e67-e76.

    Google Scholar 

  53. Pearce DJ, Singh S, Balkrishnan R, Kulkarni A, Fleischer AB, Feldman SR. The negative impact of psoriasis on the workplace. J Dermatolog Treat. 2006;17;24-28.

    Google Scholar 

  54. Reich K, Schenkel B, Zhao N, et al. Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: results from PHOENIX 2. J Dermatolog Treat. 2011;22:337-347.

    Google Scholar 

  55. Chan B, Hales B, Shear N, et al. Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasis. J Cutan Med Surg. 2009;13:192-197.

    Google Scholar 

  56. Feldman SR, Fleischer AB, Reboussin DM, et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol. 1997;37:564-569.

    Google Scholar 

  57. Kotsis K, Voulgari PV, Tsifetaki N et al. Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life. Arthritis Care Res (Hoboken). 2012;64:1593-1601.

    Google Scholar 

  58. Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke MA. Adherence in the treatment of psoriasis: a systematic review. Dermatology. 2011;222:363-374.

    Google Scholar 

  59. Richards HL, Fortune DG, Griffiths CEM. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol. 2006;20:370-379.

    Google Scholar 

  60. Kimball AB, Gladman D, Gelfand JM, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008;58:1031-1042.

    Google Scholar 

  61. Daudén E, Castañeda S, Suárez C, et al. Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol. 2013;27:1387-1404.

    Google Scholar 

  62. Ljosaa TM, Rustoen T, Mörk C, et al. Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics. Acta Derm. Venereol. 2010;90:39-45.

    Google Scholar 

  63. McKenna KE, Stern RS. The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort. J Am Acad Dermatol. 1997;36:388-394.

    Google Scholar 

  64. Sampogna F, Gisondi P, Melchi CF, Amerio P, Girolomoni G, Abeni D. Prevalence of symptoms experienced by patients with different clinical types of psoriasis. Br J Dermatol. 2004;151:594-599.

    Google Scholar 

  65. Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969-973.

    Google Scholar 

  66. Amatya B, Wennersten G, Nordlind K. Patients’ perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study. J Eur Acad Dermatol Venereol. 2008;22:822-826.

    Google Scholar 

  67. Globe D, Bayliss MS, Harrison DJ. The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups. Health Qual Life Outcomes. 2009;7:62.

    Google Scholar 

  68. Choi J, Koo JYM. Quality of life issues in psoriasis. J Am Acad Dermatol. 2003;49:S57-S61.

    Google Scholar 

  69. Zachariae R, Zachariae C, Ibsen HHW, Mortensen JT, Wulf HC. Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Derm Venereol. 2004;84:205-212.

    Google Scholar 

  70. Wahl A, Moum T, Hanestad BR, Wiklund I. The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis. Qual Life Res. 1999;8:319-326.

    Google Scholar 

  71. Ljosaa TM, Mork C, Stubhaug A, Moum T, Wahl AK. Skin pain and skin discomfort is associated with quality of life in patients with psoriasis. J Eur Acad Dermatol Venereol. 2012;26:29-35.

    Google Scholar 

  72. Feuerhahn J, Blome C, Radtke MA, Augustin M. Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis. Arch Dermatol Res. 2012;304:433-441.

    Google Scholar 

  73. Blome C, Augustin M, Behechtnejad J, Rustenbach SJ. Dimensions of patient needs in dermatology: subscales of the patient benefit index. Arch Dermatol Res. 2011;303:11-17.

    Google Scholar 

  74. Krenzer S, Radtke M, Schmitt-Rau K, Augustin M. Characterization of patient-reported outcomes (pro) in moderate to severe psoriasis. Dermatology. 2011;223:80-86.

    Google Scholar 

  75. Bhatti ZU, Salek MS, Finlay AY. Major life changing decisions and cumulative life course impairment. J Eur Acad Dermatol Venereol. 2011;25:245-246.

    Google Scholar 

  76. Augustin M, Alvaro-Gracia JM, Bagot M, et al. A framework for improving the quality of care for people with psoriasis. J Eur Acad Dermatol Venereol. 2012;26:1-16.

    Google Scholar 

  77. Mrowietz U, Kragballe K, Nast A, Reich K. Strategies for improving the quality of care in psoriasis with the use of treatment goals– a report on an implementation meeting. J Eur Acad Dermatol Venereol. 2011;25:1-13.

    Google Scholar 

  78. Jankowiak B, Sekmistrz S, Kowalewska B, Niczyporuk W, Krajewska-Kulak E. Satisfaction with life in a group of psoriasis patients. Postepy Dermatol Alergol. 2013;30:85-90.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Manchester, Salford Royal Foundation Hospital, Manchester, UK

    Matthias Augustin & Marc Alexander Radtke

Authors
  1. Matthias Augustin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc Alexander Radtke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Manchester, United Kingdom

    Richard Warren

  2. Montreal, Québec, Canada

    Alan Menter

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Augustin, M., Radtke, M.A. (2016). Quality of life in psoriasis. In: Warren, R., Menter, A. (eds) Handbook of Psoriasis and Psoriatic Arthritis. Adis, Cham. https://doi.org/10.1007/978-3-319-18227-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18227-8_7

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-18226-1

  • Online ISBN: 978-3-319-18227-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation